We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HARL:TASEHarel Insurance Investments & Financial Services Ltd. Analysis

Data as of 2026-05-18 - not real-time

$28.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading above its short‑term and medium‑term moving averages, and the MACD indicator shows a bullish crossover, suggesting upward momentum. However the RSI is in the overbought zone, indicating a potential short‑term pullback as price approaches a nearby resistance level. Volume has been trending upward, supporting the price move, while the beta is exceptionally low, implying minimal sensitivity to broader market swings. Volatility over the recent month is moderate, keeping price swings within a manageable range.
Fundamentally the company delivers strong revenue growth and impressive operating margins, while its price‑to‑earnings multiple is well below the industry average, pointing to an undervalued valuation. A dividend yield that ranks among the higher in the sector, coupled with a payout ratio well under half of earnings, signals sustainable income for shareholders. Return on equity is solid, and despite a sizable debt balance, cash reserves and equity appear sufficient to service obligations. Overall, the combination of attractive valuation, robust earnings, and a reliable dividend makes the stock appealing, though regulatory headwinds typical for regional banks remain a consideration.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI overbought condition
  • Price near resistance level
  • Moderate volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued PE relative to peers
  • Strong revenue growth
  • Sustainable dividend

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Low beta indicating defensive profile
  • Solid return on equity
  • Potential sector recovery

Key Metrics & Analysis

Financial Health

Revenue Growth31.60%
Profit Margin35.68%
P/E Ratio8.6
ROE13.01%
ROA1.30%
P/B Ratio1.1
Industry P/E16.6

Technical Analysis

TrendBullish
RSI70.6
Support$27.25
Resistance$28.15
MA 20$27.57
MA 50$27.22
MA 200$25.51
MACDBullish
VolumeIncreasing
Fear & Greed Index88.91

Valuation

GradeUndervalued
TypeBlend
Dividend Yield5.00%

Risk Assessment

Beta0.05
Volatility8.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.